Table 3.
NAFLD(+) | p* | ||
Lean | PCOS | 11 (27.5%) | 0.041 |
Control | 3 (8.8%) | ||
Overweight / obese |
PCOS | 26 (60.5%) | 0.118 |
Control | 19 (79.2%) |
Comparison of non-alcoholic fatty liver disease (NAFLD) presence between polycystic ovary syndrome and control groups in lean (body mass index [BMI ≤ 25]) participants and overweight/obese (body mass index > 25]) participants. All lean patients had a fatty liver index lower than 30.
Chi-square test.
NAFLD (+): NAFLD is diagnosed with USG